Canada · Delayed Price · Currency is CAD ASEP Medical Holdings Company Description
ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics.
It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and antifouling coating.
The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021.
ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
| Country | Canada |
| Founded | 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Robert E. Hancock |
Contact Details
Address: 4400 Chatterton Way Victoria, British Columbia V8X 5J3 Canada | |
| Phone | 604-362-3654 |
| Website | asepmedical.com |
Stock Details
| Ticker Symbol | ASEP |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA04368A1057 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Robert E. W. Hancock FRSC, OC, Ph.D. | Founder, Chief Executive Officer and Executive Chairman |
| Jacqueline M. Tucker F.C.A., FCPA | Chief Financial Officer |
| Timothy William Murphy | Chief Operating Officer, Corporate Secretary and Director |
| Dr. Evan Haney | Chief Scientific Officer |
| Dr. Fadia Saad M.B.A., Ph.D. | Chief Business Development Officer |